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Long-Term Efficacy and Rotational Stability of AcrySof 
Toric Intraocular Lens Implantation in Cataract Surgery
Myung Hun Kim, Tae-Young Chung, Eui-Sang Chung
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Purpose: To evaluate the long-term efficacy and rotational stability of the AcrySof toric intraocular lens (IOL) in cor-
recting preoperative astigmatism in cataract patients.
Methods: This prospective observational study included 30 eyes from 24 consecutive patients who underwent im-
plantation of an AcrySof toric IOL with micro-coaxial cataract surgery between May 2008 and September 2008. 
Outcomes of visual acuity, refractive and keratometric astigmatism, and IOL rotation after 1 day, 1 month, 3 
months, and long-term (mean, 13.3±5.0 months) follow-up were evaluated. 
Results: At final follow-up, 73.3% of eyes showed an uncorrected visual acuity of 20/25 or better. The postoperative 
keratometric value was not different from the preoperative value; mean refractive astigmatism was reduced to 
-0.28±0.38 diopter (D) from -1.28±0.48 D. The mean rotation of the toric IOL was 3.45±3.39 degrees at final fol-
low-up. One eye (3.3%) exhibited IOL rotation of 10.3 degrees, the remaining eyes (96.7%) had IOL rotation of 
less than 10 degrees.
Conclusions: Early postoperative and long-term follow-up showed that implantation of the AcrySof toric IOL is an ef-
fective, safe, and predictable method for managing corneal astigmatism in cataract patients.
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Given that cataract surgery has become a refractive proce-
dure, emmetropia is now the expected outcome of both the 
surgeon and most patients. Approximately 20% of patients 
having routine cataract surgery have visually significant cor-
neal astigmatism [1]. To achieve emmetropia, these patients 
may have combined corneal refractive surgery and spherical 
intraocular lens (IOL) implantation or toric IOL implantation 
alone.
The toric IOL was devised by Shimizu et al. [2] in 1994 
and has been used clinically since then. Several studies have 
analyzed the results of implantation of many models of toric 
IOLs and have found this method to be effective in correcting 
astigmatism [3-10].
The AcrySof toric series of IOLs (Alcon Laboratories, Fort 
Worth, TX, USA) is made of hydrophobic acrylate and shares 
the same biconvex single-piece design as the AcrySof SA60AT 
monofocal IOL (Alcon Laboratories). The toric IOL differs 
in that there is a toric component located on the posterior 
surface of the lens optic. The optic is marked with 3 periph-
eral dots that indicate the cylindrical axis of the lens and 
thus enable its correct alignment with the steepest axis of 
corneal astigmatism during surgery. The AcrySof toric IOL 
is available in 3 types: SA60T3, SA60T4, and SA60T5 with 
cylinder powers at the IOL plane (corneal plane) of 1.50 di-
opter (D) (1.03 D), 2.25 D (1.55 D), and 3.00 D (2.06 D), 
respectively.
The success of a toric IOL can be judged not only by its 
ability to reduce refractive astigmatism immediately post-
operatively, but also by its ability to maintain a stable posi-
tion in the capsular bag over the long-term. However, many 
surgeons have stopped using toric IOLs because of reported 
positional instability [11]. The most frequent cause of IOL 
rotation following uncomplicated cataract surgery is capsu-
lar bag shrinkage due to fibrosis [12]. The majority of this 
occurs within the first three months after implantation [13]. 
Even a small rotational deviation of the toric IOL from its 
intended axis can result in a large reduction of the astigmatic 
correction [14]. For example, a deviation of 10 degrees min-
imizes the potential correction by 35%.Korean J Ophthalmol Vol.24, No.4, 2010
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Table 1. Patient demographics and preoperative data
No. of patients (eyes) 24 (30)
Age (yr) 55.8±16.2 (31-84)
Sex (male/female) 11/13
Follow-up period (mon) 13.3±5.0
Preoperative visual acuity (logMAR)
     Uncorrected visual acuity 0.87±0.67
     Best-corrected visual acuity 0.48±0.42
Keratometric cylinder (D)
     Manual keratometer 1.57±0.51 (1.00-3.88)
     Optical coherence biometry (IOL master) 1.63±0.43 (1.00-3.76)
     Scheimpflug SimKs (Pentacam) 1.67±0.60 (1.00-3.90)
Toric IOL spherical equivalent (D) 19.8±2.10 (15.0-23.5)
Toric IOL cylinder power (D) (corneal plane) 1.48±0.48 (1.03-2.06)
LogMAR=logarithm of the minimum angle of resolution; D=diopter; IOL=intraocular lens.
Previous studies have examined the visual outcomes over 
a short period (3 to 6 months); however, to our knowledge no 
long-term studies regarding this type of IOL are available. 
The aim of this study was to assess the astigmatic reduction 
and rotational stability in the early postoperative period and 
at long-term follow-up of the AcrySof toric IOL in a series of 
cataract surgery patients with corneal astigmatism greater 
than 1.0 D.
Materials and Methods
This prospective observational study included 30 eyes 
from 24 consecutive patients with cataracts and preexisting 
regular corneal astigmatism of greater than 1.0 D who un-
derwent implantation of an AcrySof toric IOL from May 
2008 to September 2008. Preoperatively, patients had a 
complete ophthalmologic examination including measure-
ment of uncorrected visual acuity (UCVA) and best spec-
tacle- corrected visual acuity (BCVA), manifest refraction, 
autorefractometry (ARK-30; Nidek Co. Ltd., Gamagori, 
Japan), slitlamp examination, fundoscopy, keratometry, and 
topography (Orbscan II; Bausch & Lomb, TX, USA and 
Pentacam; Oculus, Wetzlar, Germany). Exclusion criteria 
included a history of glaucoma or retinal detachment, corneal 
disease, previous corneal or intraocular surgery, abnormal 
iris, pupil deformation, macular degeneration or retinopathy, 
and evidence of previous uveitis. 
Biometry was performed with optical coherence biometry 
(IOL master; Carl Zeiss Meditec, Jena, Germany) using the 
SRK-T formula for the IOL power calculation and the 
A-constant of 118.7 for the toric IOL. Data for IOL calculation 
were taken from direct use of the IOL master. The target post-
operative spherical equivalent was emmetropia. Intraocular 
lens cylinder power and alignment axis were calculated us-
ing a program available from the IOL manufacturer 
(www.acrysoftoriccalculator.com), taking into account the 
IOL master keratometry readings as well as mandatory data 
input on the position of the incision and the estimate of surgi-
cally induced astigmatism from the temporal incision (0.3 D 
for ESC, 0.5 D for TYC).
Preoperatively, with the patient sitting upright the toric 
reference corneal marker (AE-2793S; ASICO, Westmont, 
IL, USA) was used to place 3 limbal reference marks at the 
3, 6, and 9 o’clock positions to correct for recumbent 
cyclotorsion. Intraoperatively, the actual implantation axis 
was marked using a Mendez ring and a toric axis marker 
(AE-2740; ASICO). Cataract surgery was performed by 
one of 2 experienced surgeons (ESC and TYC) under topical 
anesthesia. Each patient underwent microincision cataract 
surgery using the Infinity Vision System
®and OzilTM 
Torsional Handpiece (Alcon Laboratories) with a 2.2 mm 
temporal clear corneal incision. The toric IOL was implanted 
into the capsular bag with a Monarch injector and a D-Cartridge 
(Alcon Laboratories). The IOL was rotated to its final posi-
tion by exactly aligning the toric reference marks with the 
limbal implantation axis marks. Postoperatively, prednisolone 
eyedrops and levofloxaxcin eyedrops were used 4 times a 
day for 1 week and then tapered over 3 weeks or as clin-
ically indicated.
Follow-up examinations were performed postoperatively 
at 1 day, 1 month, 3 months, and every 6 months thereafter. 
On each occasion, all patients underwent UCVA, BCVA, 
manual refraction, autorefractometry, and slit lamp examination. 
As part of the regular postoperative follow-up, digital retro-
illuminated slitlamp photographs were taken of each eye at 
every visit. Before slit lamp photography, eyes were dilated 
to a pupil diameter of at least 6.5 mm with a drop of 0.5% 
tropicamide and 0.5% phenylephrine mixed eye drops. 
Rotation was assessed by digital image analysis using the 
software program ImageJ (available at: http://rsb.info.nih.gov/ij/) 
distributed by the National Institutes of Health.
Statistical analysis was performed using Stata ver. 10 
(StataCorp LP, College Station, TX, USA). The t-test was 
used for comparative statistics. Differences were consid-
ered statistically significant when the p-value was less than 
0.05. MH Kim, et al. The Result of the AcrySof Toric IOL Implantation 
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Fig. 1. Visual outcomes. Both postoperative uncorrected visual acuity (UCVA) and best spectacle‐corrected visual acuity (BCVA) were sig-
nificantly improved when compared with preoperative values (p<0.05) (mean final follow‐up, 13.3±5.0 months). LogMAR=logarithm 
of the minimum angle of resolution.
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Fig. 2. Refractive outcome. Mean refractive cylinder significantly 
improved compared to preoperative values during all follow-up pe-
riods (mean final follow-up, 13.3±5.0 months). D=diopter.
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Fig. 3. Change in refractive cylinder. D=diopter.
Results
Thirty eyes from 24 consecutive patients were enrolled in 
this study. Table 1 shows the patients’ demographics. The 
mean age was 55.8±16.2 years and the mean follow-up peri-
od was 13.3±5.0 months. The mean preoperative sphere and 
preoperative cylinder measured by autorefractometry was 
-1.88±3.58 D and -1.28±0.48 D, respectively. The mean ker-
atometric cylinder was -1.57±0.51 D by manual keratometer. 
The keratometric cylinder measured by optical coherence 
biometry and corneal topography was -1.63±0.43 D and 
-1.67±0.60 D, respectively. There was no statistical differ-
ence of keratometric cylinder among the 3 methods.
Fig. 1 shows the mean visual results at the early and final 
follow-up visits. At the last visit, the mean logarithm of the 
minimum angle of resolution (logMAR) UCVA was 0.33±0.18. 
The BCVA improved slightly to 0.10±0.05 logMAR. 
There was significant reduction in refractive astigmatism 
after toric IOL implantation (p<0.05) (Fig. 2). The mean re-
duction was 1.01±0.40 D. At final follow-up, the mean re-
fractive cylinder was -0.28±0.38 D. All eyes had less than 1.0 
D of cylinder and 86.7% were within 0.5 D after 1 year (Fig. 
3). The mean change in keratometric astigmatism was 
0.18±0.39 D and the corneal astigmatism did not sig-
nificantly change following surgery (p=0.360). 
The mean absolute toric IOL axis rotation was 3.45±3.39 
degrees (range, 0 to 10.3 degrees) at final follow-up at 
13.3±5.0 months. One eye (3.3%) had IOL rotation of 10.3 
degrees, the remaining eyes (96.7%) had rotations of less 
than 10 degrees. Twelve (40%) IOLs rotated clockwise with 
a maximum rotation of 10.3 degrees, 10 (33.3%) IOLs ro-
tated counterclockwise with a maximum rotation of 8.9 de-
grees, and 8 (26.7%) IOLs did not rotate (Fig. 4). The mean 
absolute rotation of the toric IOL was 3.26±3.54 degrees at 1 
day postoperatively, 3.18±3.28 degrees at 1 month post-
operatively, and 3.40±3.05 degrees at 3 months post-Korean J Ophthalmol Vol.24, No.4, 2010
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Fig. 4. Rotation of toric intraocular 
lenses at final follow‐up.
Fig. 5. Mean absolute rotation of the toric intraocular lens over time 
(mean final follow-up, 13.3±5.0 months).
operatively (Fig. 5). Between day 1 and 3 months, the overall 
mean absolute rotation of all 30 implanted IOLs was 
0.71±0.84 (range, 0 to 2.1) degrees. Between 3 months post-
operatively and final follow-up (of 13.3±5.0 months) the 
mean absolute rotation was 3.46±3.39 degrees. There was no 
statistically significant rotation between early follow-up (1 
month and 3 months) and final follow-up (p=0.215, p=0.492, 
respectively).
No complications were encountered during the intra- and 
postoperative courses. None of the lenses required secondary 
alignment.
Discussion
Corneal astigmatism can be surgically managed using 
corneal, relaxing, or limbal incisions and excimer laser 
keratectomy. All these methods have limitations, including 
the degree of astigmatism that can be treated and long-term 
mechanical instability [15]. In addition, postoperative out-
comes are subject to many other variables such as age, mag-
nitude, and incision number, depth, and length. The use of 
toric IOLs to correct corneal astigmatism is one surgical op-
tion, and implantation of a toric IOL is one way to manage 
astigmatism in patients with cataract and corneal astigmatism.
It is important to obtain accurate corneal astigmatism 
measurements to determine the actual amount of cylinder re-
quiring correction and the appropriate spherical power for 
the IOL. In the AcrySof clinical trial [16], manual kera-
tometry was mandatory to measure corneal astigmatism. In 
our study, we used 3 different methods: manual keratometry, 
optical coherence biometry, and corneal topography; all 3 
methods yielded comparable results. In addition, the IOL 
cylinder power and alignment axis calculated with the kera-
tometric cylinder value from the three methods were not 
different. The p-values were 0.375 (manual keratometry and 
optical coherence biometry), 0.236 (manual keratometry and 
topography), and 0.485 (optical coherence biometry and top-
ography). The difference in the alignment axis was 
5.14±5.03 degrees, this was calculated by manual kera-
tometry and optical coherence biometry. The difference be-
tween manual keratometry and corneal topography was 
9.42±11.76 degrees. The result from optical coherence bio-
metry and corneal topography yielded 10.24±13.33 degrees 
of difference. Although we primarily used data from the IOL 
master to calculate the IOL power, we believe that any method 
could be appropriate for measuring the amount and axis of 
astigmatism depending on the clinical settings. 
The major requirement for toric IOLs is rotational stability. 
The magnitude of cylinder corrected is inversely propor-
tional to the degree of axis misalignment between 0 degrees 
and 30 degrees. It has been estimated that approximately 1 
degree of off-axis IOL rotation results in a loss of up to 3.3% 
of IOL cylinder power. Complete loss of cylinder power oc-
curs when the IOL is misaligned by more than 30 degrees 
[17]. Earlier models of toric IOLs were restricted by consid-MH Kim, et al. The Result of the AcrySof Toric IOL Implantation 
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erable amounts of postoperative rotation and the need for ad-
ditional surgical procedures to realign the IOL; IOL design 
has been shown to play a significant role in rotational stabil-
ity [5,10,18]. Weinand et al. [19] found excellent rotational 
stability for the single-piece AcrySof SA60AT IOL, which 
utilizes a design similar to the toric IOL we used. The mean 
postoperative rotation was 0.7 degrees (range, 0.1 to 1.8 de-
grees) in 17 patients. Since then few studies have actually 
used the AcrySof toric IOL. Zuberbuhler et al. [20] reported 
in a series of 44 AcrySof toric IOLs that the postoperative ro-
tation was within 5 degrees in 95% of cases and within 2 de-
grees in 68% of eyes after 3 months postoperatively. In 30 
eyes, Mendicute et al. [21] demonstrated a mean toric IOL 
axis rotation of 3.63±3.11 degrees, with rotation less than 10 
degrees in 96.7% of eyes using the AcrySof toric IOL. In our 
study, the mean axis rotation was 3.40±3.05 degrees at 3 
months postoperatively. Our early follow-up results are in 
accordance with the previous literature, implying that the 
AcrySof toric IOL has good rotational stability during the 
early follow-up period. In addition, after longer follow-up of 
more than 1 year, the mean rotation of the IOL was 3.45±3.39 
degrees and was not significantly different from early fol-
low-up results. The largest rotation was 10.3 degrees and was 
seen in only one eye. No specific cause was identified for this 
large deviation and the patient did not require secondary re-
positioning of the lens because of visual satisfaction.
The mean rotation of the toric IOLs was 3.26±3.54 degrees 
at 1 day postoperatively, 3.40±3.05 degrees at 3 months post-
operatively, and 3.45±3.39 degrees at final follow-up. Most 
IOL rotation happened in the early postoperative period. 
Once the anterior and posterior capsules fuse, IOL rotation 
was less frequent at long-term follow-up (mean, 13.3±5.0 
months). Possible factors influencing the capsule fusion and 
resultant IOL stability include capsulorhexis size and IOL 
design and material. Ruhswurm et al. [5] found IOL rotation 
to be associated with increasing capsular bag diameter as 
well as with axial length. The initial IOL position could af-
fect how gravity influences early rotation. To evaluate multi-
ple possible factors on IOL rotation, further prospective 
comparative study is warranted.
In our study, 93.3% of eyes showed 20/40 or better UCVA 
and 73.3% of eyes showed 20/25 or better UCVA at final fol-
low-up at a mean of 13.3 months. This compares favorably 
with results in the initial FDA clinical trial in which approx-
imately 66% of patients with unilateral implantation of the 
toric IOL achieved a UCVA of 20/25 or better and 41% of the 
unilateral control subjects achieved a UCVA of 20/25 or bet-
ter in 6-month data [11]. The FDA trial was originally de-
signed to follow for 1 year, but only 6 months of data are 
available. In another study of the AcrySof toric IOL without 
a control group by Mendicute et al. [21], 66.6% of eyes ach-
ieved 20/25 or better and 93.3% of eyes achieved 20/40 or 
better UCVA at 3 months postoperatively. Some studies 
[20-22] demonstrated good short-term results, but as far as 
we know ours is the first study which showed the long-term 
efficacy of the AcrySof toric IOL past 1 year.
Eyes in our study had an 85.6% reduction in astigmatism 
after AcrySof toric IOL implantation. All eyes were within 
1.0 D and 86.7% were within 0.5 D. Mendicute et al. [21] re-
ported a reduction in astigmatism of 70% after AcrySof toric 
IOL implantation. A study by Sun et al. [6] showed a reduc-
tion in astigmatism of approximately 54% after Staar TF IOL 
implantation. Till et al. [8] found a higher percentage of re-
duction (81%) after Staar TF or TL IOL implantation. De 
Silva et al. [10] reported a reduction in astigmatism of 65% 
after MicroSil 6116TU (HumanOptics, Erlangen, Germany) 
toric IOL implantation. Differences between IOL models 
and preoperative astigmatism values are responsible for the 
variability in the percentage of astigmatism reduction and 
visual acuity outcomes between toric IOLs.
Selection of the appropriate toric IOL is made using a 
manufacturer IOL program that works on the basis of pre-
operative corneal astigmatism for the power and axis 
parameters. Keratometric corneal cylinder, measured by the 
IOL master in this study, is used to calculate the required IOL 
cylinder. Therefore, toric IOL implantation should be per-
formed through small incisions to achieve expected out-
comes based on keratometric values. In previous studies of 
the AcrySof toric IOL, the incision size for cataract surgery 
has ranged from 2.75 to 3.0 mm. In our study, microincision 
cataract surgery with a 2.2 mm clear corneal incision was 
performed. The outcome was favorable as in other studies 
and no complications related to the microincision cataract 
surgery were observed. Thus, surgeons may consider a com-
bination of microincision cataract surgery and toric IOL im-
plantation to correct astigmatism in cataract patients.
In conclusion, the results from our study show that micro-
incision cataract surgery with implantation of the AcrySof 
toric IOL is a safe, predictable, and effective surgical option 
for correcting preexisting astigmatism during cataract 
surgery. The AcrySof toric IOL demonstrated no significant 
rotation during the long-term follow-up period of over a year. 
The toric IOL will play an increasingly important role in the 
future. Decreasing spectacle dependence improves patient 
quality of life and should be pursued. Thus, prospective com-
parative study with larger samples should continue to eval-
uate the efficacy of allowing spectacle independence.  
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